Phase 2 Obstructive Sleep Apnea Clinical Trials
22 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 22 trials
Recruiting
Phase 1Phase 2
Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia
Hypoxia, BrainBlood PressureStroke+5 more
University of Calgary12 enrolled1 locationNCT03255408
Recruiting
Phase 1Phase 2
Atomoxetine and DAW2022 on OSA Severity
Obstructive Sleep Apnea
Brigham and Women's Hospital18 enrolled1 locationNCT05350215
Recruiting
Phase 1Phase 2
Low-Tech Treatments for Obstructive Sleep Apnea
Traumatic Brain Injury (TBI)Obstructive Sleep Apnea (OSA)
Uniformed Services University of the Health Sciences60 enrolled1 locationNCT07301710
Recruiting
Phase 2
Dexmedetomidine Versus Propofol Sedation for Drug-Induced Sleep Endoscopy in Pediatric Obstructive Sleep Apnea
Obstructive Sleep Apnea
Erin Kirkham90 enrolled1 locationNCT05303987
Recruiting
Phase 2
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
Chronic Obstructive Pulmonary DiseaseObstructive Sleep ApneaOverlap Syndrome
University of California, San Diego240 enrolled1 locationNCT05237505
Recruiting
Phase 1Phase 2
Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities
Obstructive Sleep Apnea
VA Office of Research and Development60 enrolled1 locationNCT05558501
Recruiting
Phase 2
Study to Examine the Effect of Silicone Mouth Tape on Snoring and Mild Sleep Apnea.
SnoringMild Obstructive Sleep Apnea
Johns Hopkins University100 enrolled1 locationNCT06587256
Recruiting
Phase 1Phase 2
DRonabinol Treatment of OSA
Obstructive Sleep Apnea
VA Office of Research and Development120 enrolled1 locationNCT06477952
Recruiting
Phase 2
Endotypic Traits and Obstructive Sleep Apnea Surgery
Obstructive Sleep Apnea
University of California, Los Angeles150 enrolled2 locationsNCT05953610
Recruiting
Phase 2
Phototherapy for Non-responders to Oral Appliance Therapy for Obstructive Sleep Apnea
Obstructive Sleep Apnea
University of Alberta528 enrolled1 locationNCT06960200
Recruiting
Phase 2
Down Syndrome Obstructive Sleep Apnea
Obstructive Sleep ApneaDown Syndrome
Brigham and Women's Hospital230 enrolled7 locationsNCT06043440
Recruiting
Phase 1Phase 2
Trazodone on OSA Endotypes
Obstructive Sleep Apnea
Brigham and Women's Hospital18 enrolled1 locationNCT06286189
Recruiting
Phase 2
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
Obstructive Sleep Apnea
University of California, San Diego60 enrolled1 locationNCT05804084
Recruiting
Phase 2
Do Endotypes Predict Response and Sequelae in OSA Patients
SleepObstructive Sleep ApneaSleep Disorder+2 more
University of California, San Diego200 enrolled1 locationNCT04875364
Recruiting
Phase 2
Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome
Obstructive Sleep ApneaDown Syndrome
University of Arizona36 enrolled1 locationNCT05933603
Recruiting
Phase 1Phase 2
Rescue Pharmacotherapy for OSA
Obstructive Sleep Apnea
Brigham and Women's Hospital70 enrolled1 locationNCT05293600
Recruiting
Phase 1Phase 2
Pharmacological Activation of HMN for OSA Aim 2
Obstructive Sleep Apnea
Brigham and Women's Hospital16 enrolled1 locationNCT03858751
Completed
Phase 2
Surfactant for Obstructive Sleep Apnea in Patients with Primary Sjogren’s Syndrome: A randomised, placebo controlled study.
obstructive sleep apnea in patients with primary sjogren's syndrome.
Adelaide Institute for Sleep Health14 enrolled1 locationACTRN12612000113853
Not Yet Recruiting
Phase 2
Polidocanol sclerotherapy of pharyngx for obstructive sleep apnea (OSA) and snoring subjects(SS)
Obstructive sleep apnea syndrome (OSAS)Snoring subjects (SS)
Youliang Yin30 enrolled1 locationACTRN12606000444583
Not Yet Recruiting
Phase 2
An initial factorial evaluation of the potential synergy between two novel agents (CB0011 and CB0012) for the treatment of Obstructive Sleep Apnea Syndrome
Obstructive Sleep Apnea Syndrome
Cypress Bioscience, Inc100 enrolled1 locationACTRN12605000689673